JX5 shows cytotoxicity against Jurkat cells with IGF2BP2 overexpressed but only mild inhibition in normal Jurkat cells, suggesting therapeutic potential for IGF2BP2‐positive leukaemia. Here, IGF2BP2 is linked to leukemia.